| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.077 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.6 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.083 | 0.6 |